A new report from the US government shows that the use of antidepressants in youths dropped 10% in 2004.

After intense public debate, high-profile government meetings and a slew of warnings from the FDA, drug manufacturers like Eli Lilly (Prozac) and GlaxoSmithKline (Paxil) reported a significant drop in 4th quarter sales of nearly 16%.

The drop in drug usage reportedly began in early 2004 and steadily declined after the FDA issued reports of suicidal attempts among kids using certain anti-depressants. Drug manufacturers indicate that precautionary black-box label warnings, now required by the FDA, contributed to the overall decline.

Comments are closed.